Literature DB >> 30756209

Phenotypic differences in early outgrowth angiogenic cells based on in vitro cultivation.

Tyler D Bammert1, Collin A Beckstrom1, Grace Lincenberg1, Jamie G Hijmans1, Jared J Greiner1, Natalia G Rocha2,3.   

Abstract

Bone marrow-derived early outgrowth cells play an important role in endothelial repair. In vitro isolation techniques have identified two distinct morphological early outgrowth cell populations, but it is still unknown whether they present some functional phenotypic differences. Accordingly, the aim of the present study was to determine whether there are phenotypic differences in cellular function between two putative early outgrowth cells in culture. Peripheral blood samples were collected from 18 healthy adults. Thereafter, mononuclear cells were isolated by Ficoll density-gradient centrifugation and plated on 6-well plates coated with human fibronectin. After 2 and 7 days, respectively, non-adherent cells (NAC) and adherent cells (AC) underwent functional assays in order to measure the migratory capacity (Boyden chamber), angiogenic growth factor release (ELISA) and apoptosis (TUNEL). Migration to both VEGF (517 ± 74 vs. 273 ± 74 AU) and SDF-1 (517 ± 68 vs. 232 ± 68 AU) were approximately twofold higher (P < 0.05) in the NAC when compared to AC. Release of angiogenic factors, granulocyte colony-stimulating and hepatocyte growth factor, were not different between cell types. Apoptotic response to staurosporine was significantly lower in NAC (20 ± 32 vs. 125 ± 32%). In summary, NAC and AC demonstrated functional phenotypic differences in migratory capacity and apoptotic susceptibility, which makes it difficult to compare these two early outgrowth cell populations in literature.

Entities:  

Keywords:  Angiogenic growth factors; Cell apoptosis; Cell migration; Early outgrowth cells; Endothelium

Year:  2019        PMID: 30756209      PMCID: PMC6465412          DOI: 10.1007/s10616-019-00305-6

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  19 in total

1.  Circulating endothelial progenitor cells, vascular function, and cardiovascular risk.

Authors:  Jonathan M Hill; Gloria Zalos; Julian P J Halcox; William H Schenke; Myron A Waclawiw; Arshed A Quyyumi; Toren Finkel
Journal:  N Engl J Med       Date:  2003-02-13       Impact factor: 91.245

Review 2.  Endothelial progenitor cells: characterization and role in vascular biology.

Authors:  Carmen Urbich; Stefanie Dimmeler
Journal:  Circ Res       Date:  2004-08-20       Impact factor: 17.367

3.  Endothelial nitric oxide synthase inhibition does not alter endothelial progenitor cell colony forming capacity or migratory activity.

Authors:  Greta L Hoetzer; Heather M Irmiger; Rebecca S Keith; Kimber M Westbrook; Christopher A DeSouza
Journal:  J Cardiovasc Pharmacol       Date:  2005-09       Impact factor: 3.105

Review 4.  Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells.

Authors:  David A Ingram; Noel M Caplice; Mervin C Yoder
Journal:  Blood       Date:  2005-05-19       Impact factor: 22.113

5.  Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia.

Authors:  A Kawamoto; H C Gwon; H Iwaguro; J I Yamaguchi; S Uchida; H Masuda; M Silver; H Ma; M Kearney; J M Isner; T Asahara
Journal:  Circulation       Date:  2001-02-06       Impact factor: 29.690

6.  Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals.

Authors:  Mervin C Yoder; Laura E Mead; Daniel Prater; Theresa R Krier; Karim N Mroueh; Fang Li; Rachel Krasich; Constance J Temm; Josef T Prchal; David A Ingram
Journal:  Blood       Date:  2006-10-19       Impact factor: 22.113

7.  Adult endothelial progenitor cells from human peripheral blood maintain monocyte/macrophage function throughout in vitro culture.

Authors:  Shi Ju Zhang; Hao Zhang; Ying Jie Wei; Wen Jun Su; Zhong Kai Liao; Mai Hou; Jian Ye Zhou; Sheng Shou Hu
Journal:  Cell Res       Date:  2006-06       Impact factor: 25.617

8.  Hepatocyte growth factor is a regulator of monocyte-macrophage function.

Authors:  F Galimi; E Cottone; E Vigna; N Arena; C Boccaccio; S Giordano; L Naldini; P M Comoglio
Journal:  J Immunol       Date:  2001-01-15       Impact factor: 5.422

9.  Assessing the role of hematopoietic plasticity for endothelial and hepatocyte development by non-invasive lineage tracing.

Authors:  Matthias Stadtfeld; Thomas Graf
Journal:  Development       Date:  2004-12-02       Impact factor: 6.868

10.  Genetically tagging endothelial cells in vivo: bone marrow-derived cells do not contribute to tumor endothelium.

Authors:  Joachim R Göthert; Sonja E Gustin; J Anke M van Eekelen; Uli Schmidt; Mark A Hall; Stephen M Jane; Anthony R Green; Berthold Göttgens; David J Izon; C Glenn Begley
Journal:  Blood       Date:  2004-06-08       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.